MARKET

AKYA

AKYA

Akoya Biosciences, Inc.
NASDAQ
2.490
-0.060
-2.35%
After Hours: 2.410 -0.08 -3.21% 18:16 12/20 EST
OPEN
2.460
PREV CLOSE
2.550
HIGH
2.600
LOW
2.340
VOLUME
365.65K
TURNOVER
--
52 WEEK HIGH
6.31
52 WEEK LOW
1.880
MARKET CAP
123.41M
P/E (TTM)
-2.1215
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at AKYA last week (1209-1213)?
Weekly Report · 5d ago
Market Cool On Akoya Biosciences, Inc.'s (NASDAQ:AKYA) Revenues Pushing Shares 29% Lower
Simply Wall St · 12/14 12:21
Akoya Biosciences and NeraCare Forge Exclusive Global License Agreement for Immunoprint Test Development in Melanoma Care
Barchart · 12/10 17:22
Akoya Biosciences and NeraCare enter into a license agreement
Seeking Alpha · 12/10 14:41
Akoya Biosciences, NeraCare enter exclusive global license agreement
TipRanks · 12/10 13:35
AKOYA BIOSCIENCES AND NERACARE ENTER INTO AN EXCLUSIVE GLOBAL LICENSE AGREEMENT FOR THE DEVELOPMENT AND COMMERCIALIZATION OF THE IMMUNOPRINT TEST FOR EARLY-STAGE MELANOMA PATIENT TREATMENT DECISIONS
Reuters · 12/10 13:15
Akoya Biosciences and NeraCare Enter into an Exclusive Global License Agreement for the Development and Commercialization of the Immunoprint Test for Early-Stage Melanoma Patient Treatment Decisions
Barchart · 12/10 07:15
Weekly Report: what happened at AKYA last week (1202-1206)?
Weekly Report · 12/09 09:01
More
About AKYA
Akoya Biosciences, Inc. is a life sciences technology company delivering spatial biology solutions focused on transforming discovery, clinical research, and diagnostics. It offers single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and response to therapy. It offers a full continuum of spatial phenotyping solutions to serve the diverse needs of researchers across discovery, translational and clinical research: PhenoCode Panels and PhenoCycler, PhenoImager Fusion and PhenoImager HT Instruments. Its PhenoCycler platform provides ultra-high parameter biomarker discovery, with the ability to analyze high-plex single-cell resolution across the entire tissue sample. Its PhenoImager platform enables researchers to visualize, analyze, quantify and phenotype cells in situ, in fresh frozen or formalin-fixed paraffin-embedded (FFPE) tissue sections, and tissue microarrays (TMAs).

Webull offers Akoya Biosciences Inc stock information, including NASDAQ: AKYA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AKYA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AKYA stock methods without spending real money on the virtual paper trading platform.